Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Regular injections are prescribed for severe asthma because biologic therapies target the specific immune pathways, such as IgE and interleukin-driven inflammation, that standard inhalers cannot fully control, reducing attacks and the need for oral steroids. These treatments work by blocking key molecules to interrupt the root causes of airway swelling and help improve lung function and quality of life.
There are several factors to consider when evaluating candidacy, monitoring response, and managing side effects – see complete details below.
Asthma affects millions of people worldwide. While many manage symptoms with inhalers and oral medications, some patients experience severe asthma that does not respond well to standard treatments. In these cases, regular injections—often called biologic therapies—are used to target specific immune pathways driving inflammation and airway narrowing. Understanding why these injections are prescribed, how they work, and what to expect can help you make informed decisions about your asthma care.
Severe asthma is a form of asthma that remains uncontrolled despite high-dose inhaled corticosteroids, long-acting bronchodilators, and other add-on therapies. Key features include:
Patients with severe asthma often have a reduced quality of life, missed days at work or school, and an increased risk of hospitalization.
Standard asthma therapies focus on opening airways (bronchodilators) and reducing overall inflammation (corticosteroids). However, asthma is a complex disease driven by multiple immune pathways. In some patients, certain inflammatory cells and chemical messengers remain active despite inhaled or oral medications. This residual inflammation can continue to damage airways and trigger symptoms.
Asthma inflammation involves white blood cells, antibodies, and chemical signals. Two main immune pathways often targeted in severe asthma are:
Type 2 (T2) Inflammation
Non-T2 (Non-Eosinophilic) Inflammation
Regular injections for severe asthma targets these specific pathways, blocking the key molecules that drive inflammation. By focusing on the root causes of airway swelling, biologic therapies can reduce attacks and improve lung function where inhalers alone cannot.
Biologic therapies are large, protein-based drugs designed to neutralize or block specific molecules in the immune system. Unlike traditional drugs, they are given by subcutaneous (under the skin) or intravenous (into a vein) injection every few weeks or months.
Common mechanisms include:
By interrupting these pathways, biologics reduce airway swelling, mucus production, and the likelihood of severe asthma attacks.
Patients receiving biologic injections often experience:
These benefits translate into more active days, fewer disruptions at work or school, and less worry about sudden attacks.
Not every asthma patient needs injections. Candidates typically have:
Your doctor may run blood tests, sputum analyses, and lung function tests to identify the dominant immune pathway. This "precision medicine" approach helps match you with the most effective biologic.
Starting biologic injections involves several steps:
Initial Evaluation
First Dose and Observation
Maintenance Doses
Regular Monitoring
Assessing Response
Biologic injections are generally well tolerated, but you should be aware of possible side effects:
Your healthcare team will guide you through safety measures, including emergency plans for rare severe reactions.
Long-term management includes:
Most patients who respond well to biologics can reduce or stop oral steroids, minimizing side effects like weight gain, osteoporosis, and high blood pressure.
Biologic therapies are expensive, but many insurance plans cover them for approved indications. Assistance programs from drug manufacturers can help with copays. Your asthma specialist or a specialty pharmacy team can guide you through the paperwork and financial resources.
While injections target severe asthma at its root, combining them with other measures can enhance control:
If you or a loved one struggle with worsening asthma despite standard treatments, understanding your specific symptoms is crucial to determining whether you need advanced care. Use a free Bronchial Asthma symptom checker to evaluate your symptoms and see if you may benefit from a severe asthma evaluation.
Regular injections for severe asthma targets the immune pathways driving your disease, but they require careful medical oversight. Always speak to a doctor if you experience:
Even though these treatments are highly effective, any life-threatening or serious symptoms warrant immediate medical attention. Your doctor can guide you through the evaluation, select the right biologic, and monitor your progress to keep you breathing easier and living better.
By understanding how these targeted injections work and what they involve, you can partner with your healthcare team to make informed decisions about managing severe asthma. Regular monitoring, lifestyle adjustments, and open communication with your doctor will help you get the most benefit from these advanced therapies.
(References)
* Pelaia G, Vatrella A, Pelaia C, Gallelli L. Mechanisms of action of current and future biologics for severe asthma. Expert Rev Clin Pharmacol. 2019 Sep;12(9):885-896. doi: 10.1080/17512433.2019.1650394. Epub 2019 Aug 7. PMID: 31379203.
* Bel EH. Biologics in severe asthma: how do they work and whom should we choose? Neth J Med. 2020 Jan;78(1):3-9. PMID: 32065330.
* Wenzel SE. Targeting Immune Pathways in Severe Asthma: Biologic Therapies and Future Directions. J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2596-2605. doi: 10.1016/j.jacip.2019.06.026. Epub 2019 Jun 27. PMID: 31255767.
* Lambrecht BN, Hammad H. Mechanisms of Action of Biologics for Severe Asthma. Annu Rev Med. 2021 Jan 27;72:513-532. doi: 10.1146/annurev-med-070819-032049. PMID: 33502946.
* Pelaia G, Pelaia C, Vatrella A, Gallelli L. Current and Emerging Biologics in Severe Asthma: An Overview on Mechanisms of Action, Clinical Efficacy, and Safety. Int J Mol Sci. 2023 Feb 1;24(3):2730. doi: 10.3390/ijms24032730. PMID: 36769018; PMCID: PMC9917573.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.